Technology | Magnetic Resonance Imaging (MRI) | November 21, 2017

Hitachi Healthcare Americas Introduces SynergyDrive MRI Workflow Solution

Workflow solution addresses the bottlenecks in the MRI scanning process from start to finish

Hitachi Healthcare Americas Introduces SynergyDrive MRI Workflow Solution

November 21, 2017 — At the 2017 Radiological Society of North America (RSNA) annual meeting, Nov. 26-Dec. 1 in Chicago, Hitachi Healthcare Americas (HHA) will demonstrate its SynergyDrive MR (magnetic resonance) workflow engine. SynergyDrive comprehensively addresses the bottlenecks in the MR scanning process from start to finish – from patient registration to post-processing and image sharing.

SynergyDrive is standard with the Echelon Oval 1.5T MR system that features the widest patient bore (74 cm) in the industry and the widest patient table (63 cm), according to Hitachi.

SynergyDrive addresses speed of throughput with automated patient registration, pre-population of scanning protocols, streamlined patient positioning and setup, along with its Auto Image Load feature, which helps efficiently prepare the next scan for seamless transition. The Oval provides a comfortable environment for the patient with its ultra-wide bore, wide table and various gantry tools such as gating confirmation and start/pause buttons that enable patient-side setup and scanning to occur. Features like the Workflow Integrated Technology (WIT) coil system and Auto Element Selection feature ensure an optimum setting for each patient and deliver high-quality images.

SynergyDrive also includes a number of sequences and image processing tools to improve image quality and reduce callbacks. RADAR motion compensation, FatSep, RAPID parallel imaging and non-contrast MR angiography (MRA) image sequences deliver fast, high-quality images while reducing the amount of time the patient must remain motionless.

For more information: www.hitachimed.com

Related Content

ADHD Medication May Affect Brain Development in Children

Images of regions of interest (colored lines) in the white matter skeleton representation. Data from left and right anterior thalamic radiation (ATR) were averaged. Image courtesy of C. Bouziane et al.

News | Neuro Imaging | August 16, 2019
A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
Synaptive Medical Launches Modus Plan With Automated Tractography Segmentation
Technology | Neuro Imaging | August 07, 2019
Synaptive Medical announced the U.S. launch and availability of Modus Plan featuring BrightMatter AutoSeg. This release...
Canon Medical Introduces Encore Orian MR Upgrade Program
News | Magnetic Resonance Imaging (MRI) | August 06, 2019
Canon Medical Systems USA Inc. is helping to provide low-cost patient care solutions for its customers with the launch...
FDA Issues Draft Guidance on Medical Device Safety in MRI Environment
News | Magnetic Resonance Imaging (MRI) | August 01, 2019 | Jeff Zagoudis, Associate Editor
The U.S. Food and Drug Administration (FDA) issued a new draft guidance titled Testing and Labeling Medical Devices for...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...